| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3757 | Nsc265473 | Novel substrate of ABCG2 |
|
| DCC3758 | Nsc-279287 | Novel Inhibitor of the p53-mdm2 Interaction, Activating p53-Dependent Transcription in mdm2-Overexpressing Cells |
|
| DCC3759 | Nsc-2888 | Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity |
|
| DCC3760 | Nsc-299202 | Novel potent gonist of Human G Protein-Coupled Receptor-35 (hGPR35) (EC50 8 nM) |
|
| DCC3761 | Nsc30049 | Novel inhibitor of Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations |
|
| DCC3762 | Nsc-311068 | Novel selective inhibitor of TET1 transcription and 5-hydroxymethylcytosine (5hmC) modification, effectively inhibiting cell viability in AML with high expression of TET1 |
|
| DCC3763 | Nsc-33353 | Potent inhibitor of the AcrAB-TolC efflux pump in Escherichia coli, potentiating the antibacterial activities of novobiocin and erythromycin upon binding to the membrane fusion protein AcrA |
|
| DCC3764 | Nsc-339579 | Novel potent Mycobacterium tuberculosis DHFR inhibitor |
|
| DCC3765 | Nsc339614 Potassium Salt | Selective potentiator at GluN1/GluN2C and GluN1/GluN2D receptors |
|
| DCC3766 | Nsc-347518 | DT-diaphorase inhibitor |
|
| DCC3767 | Nsc-4231 | Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity |
|
| DCC3768 | nsc48693 Dihydrochloride | Potent apoptosis inducer in pancreatic cancer cells |
|
| DCC3769 | Nsc52101 | Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein |
|
| DCC3770 | Nsc-55158 | Novel antagonist of the Grb7 SH2 domain; Antitumor Agent |
|
| DCC3771 | Nsc56452 | Novel specific inhibitor of EGF receptor autophosphorylation and cell proliferation in HeLa cells by disrupting allosteric activation of EGF-stimulated dimer |
|
| DCC3772 | Nsc-57148 | Novel antagonist of the Grb7 SH2 domain; Antitumor Agent |
|
| DCC3773 | Nsc-57774 | Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines |
|
| DCC3774 | Nsc57971 | Novel non-peptide disruptor of IKKß/NEMO complex |
|
| DCC3775 | Nsc-60339 | Novel efflux pump inhibitor (EPI) |
|
| DCC3776 | Nsc61610 | Novel activator of lanthionine synthetase C-like 2 (LANCL2), down-modulating pulmonary inflammation through the downregulation of TNF-α and MCP-1 and reduction in the infiltration of neutrophils, accelerating recovery and inducing IL-10-mediated regulator |
|
| DCC3777 | Nsc-627757 | Novel DNA repair inhibitor |
|
| DCC3778 | Nsc636795 | Novel inhibitor of ABCG2 transporter function |
|
| DCC3779 | Nsc-657186 | Novel selective non-zinc-binding MMP-2 inhibitor |
|
| DCC3780 | Nsc65847 | Novel dual inhibitor of viral and Streptococcus pneumoniae neuraminidase |
|
| DCC3781 | Nsc66098 | Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein |
|
| DCC3782 | Nsc663627 | IκBα phosphorylation inhibitor |
|
| DCC3783 | Nsc-670224 | Toxitant of Saccharomyces_cerevisiae>Saccharomyces cerevisiae |
|
| DCC3784 | Nsc-672121 | Potent CDC25A>Cdc25A inhibitor; Vitamine K3 analogue |
|
| DCC3785 | Nsc-674205 | Potent and selective nociceptin opioid receptor (NOP) agonist |
|
| DCC3786 | Nsc676914a | Novel NF-κB inhibitor |
|
